CAUWENBERGH GEERT (President & CEO) reported 1 transaction at PHIO PHARMACEUTICALS CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 8/2/2019ACC: 0001209191-19-044370
DirectorOfficer· President & CEO
Since Aug 2018
-1.75K
Net shares
Net seller
$705.65
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.75K disposed
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
−1.75K
Price / share
$0.40
Trade value
$705.65
% of position
0.4%
8/1/2019
481.59K→479.84K
Total
Net shares
−1.75K
Net value
-$705.65
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 8/1/2019 | F · Tax Withholding | −1.75K | $0.40 | $705.65 | 0.4% | 481.59K | 479.84K |
| Total | −1.75K | -$705.65 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock, $0.0001 par value
IndirectShares owned450.00
Total
450.00 indirect450.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.0001 par value | 450.00 | Indirect |
| Total | 450.00 | 450.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported